Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 15/20 | 0.81 |
| ▸ | KCNK3 | O14649 | 5/20 | 0.64 |
| ▸ | KCNK9 | Q9NPC2 | 5/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17719152 | 0.91 | SLC2A1 (0.76) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL16261531 | 0.90 | SLC2A1 (1.00) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718829 | 0.89 | SLC2A1 (0.88) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718807 | 0.88 | SLC2A1 (0.94) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718936 | 0.87 | SLC2A1 (0.86) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718896 | 0.87 | SLC2A1 (0.81) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718942 | 0.85 | SLC2A1 (1.00) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17709590 | 0.85 | SLC2A1 (0.80) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718911 | 0.83 | SLC2A1 (0.78) | SLC2A1KCNK3KCNK9 | |
| SCHEMBL17718837 | 0.83 | SLC2A1 (0.84) | SLC2A1KCNK3KCNK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160120863-A1 | SLC2A TRANSPORTER INHIBITORS | IOMET PHARMA LTD. (GB) | 2016-05-05 | — | — | US | disclosed |
| US-20160120863-A1 | SLC2A TRANSPORTER INHIBITORS | IOMET PHARMA LTD. (GB) | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160120863-A1 | SLC2A TRANSPORTER INHIBITORS | SLCO1A2, SLCO2B1, SLCO2A1 | SLC2A1 6/4885KCNK3 2898/4885KCNK9 2405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.